Ethnopharmacological relevance The medicinal plant Morinda officinalis How.(MO) and its
root have long been used in traditional medicines in China and northeast Asia as tonics for …

Osteoporosis is a bone disease characterized by increasing osseous fragility and fracture
due to the reduced bone mass and microstructural degradation. Primary pharmacological …

Osteoporosis is a systemic multifactorial bone disease characterized by low bone quality
and density and bone microstructure damage, increasing bone fragility and fracture …

A metabolic bone disorder called osteoporosis is characterized by decreased bone mass
and compromised microarchitecture. This condition can deteriorate bones and raise the risk …

The identification of Receptor activator of nuclear factor kappa B ligand (RANKL) and its
cognate receptor Receptor activator of nuclear factor kappa B (RANK) during a search for …

Osteoporosis (OP) is a highly prevalent orthopedic condition in postmenopausal women and
the elderly. Currently, OP treatments mainly include bisphosphonates, receptor activator of …

Abstract Context Morinda officinalis FC How.(MO)(Rubiaceae) can strengthen bone function.
Objective To examine the functional mechanism and effect of MO polysaccharides (MOPs) in …

Abstract Matrix metalloproteinase 2 (MMP2) is a well‑characterized protein that is
indispensable for extracellular matrix remodeling and other pathological processes, such as …

Ethnopharmacological relevance Morinda officinalis is a well-known Chinese tonic herb that
has shown clinical efficacy in the treatment of bone disease. However, its anti-osteoporotic …

Morinda officinalis How oligosaccharide (MOO) stands as one of the principal active
constituents of M. officinalis How, widely employed in traditional Chinese medicine. The …